Patents by Inventor Harvey B. Buck

Harvey B. Buck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7045310
    Abstract: Novel bipyridyl-osmium complex conjugates and their use in electrochemical assays are described. The redox reversible-osmium complexes can be prepared to exhibit unique reversible redox potentials and can thus be used in combination with other electroactive redox reversible species having redox potentials differing by at least 50 millivolts in electrochemical assays designed for use of multiple electroactive species in the same cell and in the same sample without interference between the two or more redox coupled conjugate systems.
    Type: Grant
    Filed: November 1, 2001
    Date of Patent: May 16, 2006
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Harvey B. Buck, Jr., Zhi David Deng, Eric R. Diebold
  • Patent number: 7045054
    Abstract: Sensors (10, 110, 210, 310, 410) and a method for detecting an analyte are described. Sensors (10, 110, 210, 310, 410) each have a volume of a hydrophilic medium (24) that retains an amount of analyte proportionate to the concentration of analyte in a biological fluid, electrodes (12) and a redox enzyme in contact with medium (24), and an electron transfer mediator. The fluid contacts sensors (10, 110, 210, 310, 410) and at initially predetermined intervals intermittently applies a potential to electrode (12) sufficient to oxidize the mediator and sensing current through electrode (12) as a function of the duration of the applied potential. The applied mediator oxidizing applied potential is maintained for a period of time sufficient to determine the rate of change of current with time through electrode (12). The current flow is correlated with the current flow for known concentrations of the analyte in medium (24).
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: May 16, 2006
    Assignee: Roche Diagnostics Corporation
    Inventors: Harvey B. Buck, Matthias Essenpreis
  • Publication number: 20020090632
    Abstract: Novel bipyridyl-osmium complex conjugates and their use in electrochemical assays are described. The redox reversible-osmium complexes can be prepared to exhibit unique reversible redox potentials and can thus be used in combination with other electroactive redox reversible species having redox potentials differing by at least 50 millivolts in electrochemical assays designed for use of multiple electroactive species in the same cell and in the same sample without interference between the two or more redox coupled conjugate systems.
    Type: Application
    Filed: November 1, 2001
    Publication date: July 11, 2002
    Inventors: Harvey B. Buck, Zhi David Deng
  • Patent number: 6352824
    Abstract: Novel bipyridyl-osmium complex conjugates, their preparation, and their use in electrochemical assays are described. The redox reversible-osmium complexes can be prepared to exhibit unique reversible redox potentials and can thus be used in combination with other electroactive redox reversible species having redox potentials differing by at least 50 millivolts in electrochemical assays designed for use of multiple electroactive species in the same cell and in the same sample without interference between the two or more redox coupled conjugate systems.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: March 5, 2002
    Assignee: Roche Diagnostics Corporation
    Inventors: Harvey B. Buck, Jr., Zhi David Deng
  • Patent number: 6294062
    Abstract: A method and device for detection and quantification of biologically significant analytes in a liquid sample is described. The method includes contacting a volume of a liquid sample with predetermined amounts of at least a first and second redox reversible species having redox potentials differing by at least 50 millivolts. At least one of the redox reversible species comprises a liquid sample diffusible conjugate of a ligand analog of an analyte in the liquid sample and a redox reversible label. A predetermined amount of at least one specific binding partner for each analyte to be measured is combined with the sample and current flow is measured at first and second anodic and cathodic potentials and correlated with current flows for known concentrations of the respective diffusible redox reversible species. Diagnostic devices and kits, including such devices and the specified specific binding partner(s) and redox reversible species are also described.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: September 25, 2001
    Assignee: Roche Diagnostics Corporation
    Inventors: Harvey B. Buck, Jr., Zhi David Deng, Eric R. Diebold
  • Patent number: 6262264
    Abstract: Novel imidazole-osmium complex conjugates, their preparation, and their use in electrochemical assays are described. The redox reversible-osmium complexes can be prepared to exhibit unique reversible redox potentials and can thus be used in combination with other electroactive redox reversible species having redox potentials differing by at least 50 millivolts in electrochemical assays designed for use of multiple electroactive species in the same cell and in the same sample without interference between the two or more redox coupled conjugate systems.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: July 17, 2001
    Assignee: Roche Diagnostics Corporation
    Inventors: Harvey B. Buck, Jr., Zhi David Deng
  • Patent number: 6093546
    Abstract: The invention relates to a process for making a test element, such as an analytical test element. Compositions of matter, such as analyte specific receptors, are treated to carry a charge. These are then applied to test carriers treated to carry a charge opposite that of the composition of matter. Interaction of charge fixes the composition of matter to the test element.
    Type: Grant
    Filed: September 3, 1992
    Date of Patent: July 25, 2000
    Assignee: Roche Diagnostics
    Inventors: David J. Ledden, David R. Moorman, Michael J. Kinch, Harvey B. Buck
  • Patent number: 4798577
    Abstract: Separation device and method for the fractionation and separation of finely divided solid particulate material suspended in a liquid are disclosed. The separation device comprises upper and lower portions which are joined together to form an inner cavity retaining liquid and a capillary gap which extends outwardly radially from said cavity. During rotation solid particles present in the suspending liquid pass outwardly along and/or become entrapped in the capillary gap(s).
    Type: Grant
    Filed: May 12, 1986
    Date of Patent: January 17, 1989
    Assignee: Miles Inc.
    Inventors: Allen J. Brenneman, Harvey B. Buck, Jr., Jerry T. Pugh, Steven P. Robertson